Skip to main content

Avricore Health Inc.

corporate_fare Company Profile

Avricore Health Inc.

AVCRF·OTC·Life Sciences·CIK 0001355736

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab, a wholly owned subsidiary, it provides a turnkey point-of-care testing platform intended to create value for stakeholders and better outcomes for patients. During the year ended December 31, 2019, the Company discontinued its over-the-counter (OTC) pharmaceutical products business and ceased production and sales of all generic and over-the-counter pharmaceuticals. Avricore views the community pharmacy as underutilized and is committed to supporting pharmacies' ability to deliver innovation to modern healthcare consumers. Pharmacies face reduced revenues as a result of disruptions to the sector and regulatory changes, and pharmacy owners are actively looking for innovations in service and value-added services, like HealthTab, to support business growth beyond the traditional dispensing model. Community pharmacy is expected to focus increasingly on cognitive services with attendant point-of-care testing in the future. The Company's HealthTab technology provides lab-accurate results for specific blood work within 12 minutes. Installed at the pharmacy and administered by the attending pharmacist, the platform lets a patient quickly access up to 27 bio-markers. A consumer can use a simple patient-assisted finger prick to obtain data on their health to share with their physician and healthcare team, track their health over time, measure the impacts of therapies they are undertaking, and screen for potential health risks. HealthTab allows these innovations to be accessed in a low-barrier manner at the community pharmacy level for a balanced cost. The pharmacist can also benefit from a new revenue stream, build a deeper relationship with clientele, and deliver lower-cost healthcare support.

Avricore Health Inc. (OTC:AVCRF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 7 items for AVCRF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-09, rated 7/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for AVCRF spans 6-K.

Recent high-impact activity:

  • HealthTab™ Goes National: NHS England Backs Avricore's Pharmacy Cholesterol Testing
  • Avricore Signs Multi-Year Abbott Deal for UK Point-of-Care Testing
  • Avricore Health Closes Upsized $1.254M Private Placement with Insider Participation
  • Avricore Health Secures $1.25M Private Placement to Address Going Concern
  • Avricore Health Faces Going Concern Warning Amidst 89% Revenue Drop and Increased Losses

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
CA$398.15K CAD
Net Income
-CA$1.86M CAD
Diluted EPS
-CA$0.02 CAD
Op. Cash Flow
-CA$789.93K CAD
Free Cash Flow
-CA$878.43K CAD
Gross Profit
CA$238.29K CAD
Cash & Equivalents
CA$227.92K CAD
Debt / Equity
0.00×
Net Margin
-466.8%
Source: 20-F · filed 2026-11-06 · accession 0001493152-26-050516

Dilution Risk

Low risk

Filing-implied dilution signals for AVCRF, detected from its recent SEC filings · based on capital-structure filings through 2026-07-11.

Private Placement Closed · Insider Participation

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Insider Transactions

AVCRF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with A →
$0.0008
52-week range · as of 2026-10-09 $0.0008 – $0.0787
Market cap
$3.99M
Volume
15K (0.3× avg)
3-mo avg 57.6K
Last traded · 2026-11-12

show_chartPrice Chart

Loading chart...

feed AVCRF - Latest Insights

AVCRF
Oct 09, 2026, 7:39 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.000801
Real-time Price: $0.0008 info
Change: -$0.000001 (-0.12%) info
Market Cap: $3.988M info
AVCRF
Sep 16, 2026, 6:02 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.000801
Real-time Price: $0.0008 info
Change: -$0.000001 (-0.12%) info
Market Cap: $3.988M info
AVCRF
Jul 10, 2026, 8:19 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.056
Real-time Price: $0.0008 info
Change: -$0.0552 (-99%) info
Market Cap: $3.988M info
AVCRF
Jun 11, 2026, 6:12 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.04965
Real-time Price: $0.0008 info
Change: -$0.04885 (-98%) info
Market Cap: $3.988M info
AVCRF
May 08, 2026, 7:01 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.0399
Real-time Price: $0.0008 info
Change: -$0.0391 (-98%) info
Market Cap: $3.988M info
AVCRF
Feb 17, 2026, 6:15 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.0529
Real-time Price: $0.0008 info
Change: -$0.0521 (-98%) info
Market Cap: $3.988M info
AVCRF
Jan 12, 2026, 3:09 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.03525
Real-time Price: $0.0008 info
Change: -$0.03445 (-98%) info
Market Cap: $3.988M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets